Results 221 to 230 of about 62,729 (246)

FSH

2012
J. A. M. van Balen, A. A. Demeulemeester, M. Frölich, K. Mohrmann, L. M. Harms, W. C. H. van Helden, L. J. Mostert, J.H.M. Souverijn   +7 more
openaire   +1 more source

FSH☆

2015
B.L. Furman, S. John
openaire   +1 more source

FSH

2017
David J. Piekarski, Naomi Ondrasek
openaire   +1 more source

[FSH-releasing factor (FSH-RF)].

Horumon to rinsho. Clinical endocrinology, 1967
M, Igarashi, Y, Ebara
openaire   +1 more source

Radioimmunoassay of Ovine FSH

Journal of Animal Science, 1973
C L, Kragt, J, Cons
openaire   +2 more sources

FSH

2007
Brian L. Furman, John Schriefer
openaire   +1 more source

FSH

2011
openaire   +2 more sources

[Pharmacoeconomic advantages of recombinant FSH vs urinary derived FSH].

Gynecologie, obstetrique & fertilite, 2005
Nowadays, the use of urinary FSH is essentially justified by a lower acquisition price compared to modern products generated by Biotechnology (recombinant FSH). However, the public price of a product is only one element of the total cost of a therapeutic regimen that must be taken into account in medical decision-making.
openaire   +1 more source

Long-acting recombinant FSH (FSH-CTP, Corifollitropin alfa)

2005
Peter Platteau, Paul Devroey
openaire   +1 more source

FSH

2006
openaire   +2 more sources